USPTO serial 87138173
ALSACHIM
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- May 22, 2018
- Examiner
- MALASHEVICH, JASON
- Law office
- Historical data usage
What this means
Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.
Need help with ALSACHIM?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Illkirch Graffen, FR
67400 Illkirch Graffen, FR
67400 Illkirch Graffen, FR
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jeff Goehring
Jeff Goehring Nixon & Vanderhye P.C.901 N. Glebe Road, 11th FloorArlington, VA 22203United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical preparations for biological research, biotechnological research, medical research, pharmaceutical research, and veterinary research use, including those comprised of natural materials, but not for purposes of providing medical diagnosis or treatment, and except fungicides; chemical preparations, namely, stable isotope labeled reference standards for the analytical development of mass spectrometry methods for the biological, biotechnological, medical, pharmaceutical, and veterinary research industries | ACTIVE | — |
| 005 | diagnostic kits comprised of medical diagnostic chemical reagents for testing of body fluids and body tissue via high pressure liquid chromatography, for use in detecting immunosuppressant, anticoagulant, infectious, parasitic, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, immune system and nervous system related diseases and disorders; diagnostic kits comprised of medical diagnostic chemical reagents for testing of body fluids and body tissue via liquid chromatography coupled to tandem mass spectrometry, for use in detecting immunosuppressant, anticoagulant, infectious, parasitic, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, immune system and nervous system related diseases and disorders | ACTIVE | — |
| 042 | Scientific research and development of molecules suitable for therapeutic use; scientific research and development of new procedures and experiments for the discovery, identification or improvement of molecules suitable for therapeutic use; scientific and medical laboratory services; engineering services in the field of custom synthesis of molecules suitable for therapeutic use | ACTIVE | — |
| 044 | Medical diagnostic testing services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by ALSACHIM
- Other trademarks owned by ALSACHIM
- Other trademarks owned by ALSACHIM
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named ALSACHIM
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 6, 2024 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Nov 6, 2024 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Nov 6, 2024 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| May 17, 2024 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| May 22, 2023 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Feb 28, 2021 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Feb 28, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 28, 2021 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Feb 28, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 28, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 28, 2021 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| May 22, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 6, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 6, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 14, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 29, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 26, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 26, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 26, 2018 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Aug 2, 2017 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Aug 2, 2017 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 2, 2017 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 12, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 12, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 3, 2017 | ALIE | ASSIGNED TO LIE | — |
| Jun 26, 2017 | ALIE | ASSIGNED TO LIE | — |
| May 26, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 28, 2016 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 28, 2016 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 28, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 28, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 18, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 18, 2016 | NWAP | NEW APPLICATION ENTERED | — |